Team:Paris Bettencourt/Notebook/Trojan Horse/Friday 28th June
From 2013.igem.org
(Difference between revisions)
(4 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
<div class="FU_note"> | <div class="FU_note"> | ||
<html> | <html> |
Latest revision as of 09:54, 29 July 2013
sRNA design
Red sequences:
pACYCDuet-1 (CmR) : ATATCCAGTGATTTTTTTCTCCAT
pCOLADuet-1 (KanR) : CGTTTCCCGTTGAATATGGCTCAT
We decided that targeting only two different antibiotic resistance will be enough for a proof of concept. We give up AmpR because otherwise they might be experimental issues with AmpR that is also on phagemid litmus28i.